Avacta Group (AVCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Oct 2011 07:00 AM
RNS
South East Asian Alliance agreed with Pall
19 Sep 2011 07:00 AM
RNS
Notice of Preliminary Results
09 Aug 2011 07:00 AM
RNS
Pre-close Trading Update
06 Jul 2011 07:00 AM
RNS
Change of Registered Office
13 Jun 2011 07:00 AM
RNS
Avacta & Pall Corp form new collaborative venture
10 Jun 2011 12:50 PM
RNS
Director/PDMR Shareholding
31 May 2011 07:00 AM
RNS
Avacta secures second Optim sale in US
18 Apr 2011 07:00 AM
RNS
Interim Results
12 Apr 2011 12:42 PM
RNS
Issue of Equity
29 Mar 2011 07:00 AM
RNS
Exclusive distribution agreement with DKSH Japan
28 Mar 2011 08:00 AM
RNS
Additional Listing
28 Mar 2011 07:00 AM
RNS
Additional Listing
22 Mar 2011 10:11 AM
RNS
Additional Listing
17 Mar 2011 07:00 AM
RNS
Directorate Change
04 Mar 2011 07:00 AM
RNS
Trading Statement
23 Feb 2011 07:00 AM
RNS
Re Agreement
03 Feb 2011 07:00 AM
RNS
Re Agreement
03 Feb 2011 07:00 AM
RNS
Issue of Equity
27 Jan 2011 04:55 PM
RNS
Holding(s) in Company
27 Jan 2011 07:00 AM
RNS
Director/PDMR Shareholding
26 Jan 2011 07:00 AM
RNS
Issue of Equity
25 Jan 2011 11:57 AM
RNS
Holding(s) in Company
21 Jan 2011 03:47 PM
RNS
AGM Result and Placing
12 Jan 2011 07:00 AM
PRN
Placing, Issue of Equity and related party tran...
05 Jan 2011 11:59 AM
PRN
Exercise of Warrants
04 Jan 2011 06:28 PM
PRN
Holding(s) in Company
04 Jan 2011 07:00 AM
RNS
Product Sale
31 Dec 2010 09:57 AM
PRN
Holding(s) in Company
30 Dec 2010 02:36 PM
PRN
Holding(s) in Company
25 Nov 2010 07:00 AM
RNS
Product Launch
15 Nov 2010 07:00 AM
PRN
Grant of Options to Directors
03 Nov 2010 07:00 AM
RNS
Final Results
27 Oct 2010 07:00 AM
RNS
Product Sale
26 Oct 2010 07:00 AM
PRN
Issue of Equity
14 Oct 2010 07:00 AM
RNS
Re Agreement
20 Sep 2010 07:00 AM
PRN
Licensing Agreement
07 Sep 2010 05:08 PM
PRN
Holding(s) in Company
06 Sep 2010 07:00 AM
PRN
Distribution Agreement
06 Aug 2010 09:55 AM
PRN
Director/PDMR Shareholding
29 Jul 2010 07:00 AM
PRN
Issue of Equity
06 Jul 2010 07:00 AM
PRN
Issue of Equity
01 Jun 2010 07:00 AM
PRN
Change of Adviser
30 Apr 2010 07:00 AM
PRN
Half-yearly Report
08 Mar 2010 07:00 AM
RNS
Notice of Results and Trading
03 Mar 2010 07:00 AM
RNS
Acquisition
22 Feb 2010 02:42 PM
RNS
Director/PDMR Shareholding
25 Jan 2010 07:00 AM
RNS
Result of AGM
21 Dec 2009 10:35 AM
RNS
Issue of Equity
26 Nov 2009 07:03 AM
RNS
Preliminary Results
26 Nov 2009 07:00 AM
RNS
Issue of Equity

Avacta Group plc is a United Kingdom-based life sciences company focused on improving healthcare outcomes through targeted cancer treatments and diagnostics. The Company has two segments: Therapeutics and Diagnostics. The Therapeutics segment is a clinical stage oncology biotech division harnessing therapeutic platforms to develop novel, highly targeted cancer drugs. The Diagnostics segment is focused on supporting healthcare professionals and broadening access to diagnostics.

It has two platforms: preICISION and Affimer. The Company's preICISION platform is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The preICISION platform harnesses this tumor specific protease to activate preICISION peptide drug conjugates and preICISION antibody/Affimer drug conjugates in the tumor microenvironment. Its lead preICISION program AVA6000, a peptide drug conjugate form of doxorubicin, is in Phase 1 studies.

Avacta Group share price launched at 5,448p in 2003. 

UK 100

Latest directors dealings